Expanding the phenotype associated with FOXG1 mutations and in vivo FoxG1 chromatin-binding dynamics

Clinical Genetics

Volumn 82, Issue 4, 2012, Pages 395-403

  De Filippis, R ^a   Pancrazi, L ^b,c   Bjorgo K ^d   Rosseto, A ^a   Kleefstra, T ^e   Grillo, E ^a   Panighini, A ^b   Cardarelli, F ^f   Meloni, I ^a   Ariani, F ^a   Mencarelli, Ma ^a   Hayek, J ^g   Renieri, A ^a,h   Costa, M ^b,c   Mari, F ^a,h  

^a UNIVERSITY OF SIENA   (Italy)

^b CNR   (Italy)

^c SCUOLA NORMALE SUPERIORE   (Italy)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

^g UNIVERSITY HOSPITAL OF SIENA   (Italy)

^h AOUS   (Italy)

Author keywords

Chromatin affinity; FOXG1 gene; FRAP assay; Rett syndrome

Indexed keywords

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN; PROTEIN FOXG1; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CASE REPORT; CHILD; CHROMATIN; FACIES; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FOXG1 GENE; GENE; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; SCHOOL CHILD;

ADULT; BLOTTING, WESTERN; CHILD; CHROMATIN; CHROMOSOMES, HUMAN, PAIR 15; DNA METHYLATION; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, INBORN; HUMANS; KARYOTYPING; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; PHENOTYPE; POINT MUTATION; SYNDROME;

EID: 84866148437     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01810.x     Document Type: Article

References (26)

1. Neul JL, Kaufmann WE, Glaze DG et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2011: 68 (6): 944-950.
2. Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 2000: 9: 1369-1375.
3. Monros E, Armstrong J, Aibar E, Poo P, Canos I, Pineda M. Rett syndrome in Spain: mutation analysis and clinical correlations. Brain Dev 2001: Suppl. 1: S251-S253.
4. Smeets E, Schollen E, Moog U et al. Rett syndrome in adolescent and adult females: clinical and molecular genetic findings. Am J Med Genet A 2003: 122 (3): 227-233.
5. Philippe C, Amsallem D, Francannet C et al. Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. J Med Genet 2010: 47 (1): 59-65.
6. Ariani F, Hayek G, Rondinella D et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008: 83 (1): 89-93.
7. Bahi-Buisson N, Nectoux J, Girard B et al. Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant. Neurogenetics 2010: 11 (2): 241-249.
8. Mencarelli MA, Spanhol-Rosseto A, Artuso R et al. Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet 2010: 47 (1): 49-53.
9. Le Guen T, Bahi-Buisson N, Nectoux J et al. A FOXG1 mutation in a boy with congenital variant of Rett syndrome. Neurogenetics 2011: 12 (1): 1-8.
10. Le Guen T, Fichou Y, Nectoux J et al. A missense mutation within the fork-head domain of the forkhead box G1 Gene (FOXG1) affects its nuclear localization. Hum Mutat 2011: 32 (2): E2026-E2035.
11. Kortum F, Das S, Flindt M et al. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J Med Genet 2011: 48 (6): 396-406.
12. Bisgaard AM, Kirchhoff M, Tumer Z et al. Additional chromosomal abnormalities in patients with a previously detected abnormal karyotype, mental retardation, and dysmorphic features. Am J Med Genet A 2006: 140 (20): 2180-2187.
13. Papa FT, Mencarelli MA, Caselli R et al. A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features. Am J Med Genet A 2008: 146A (15): 1994-1998.
14. Mencarelli MA, Kleefstra T, Katzaki E et al. 14q12 Microdeletion syndrome and congenital variant of Rett syndrome. Eur J Med Genet 2009: 52 (2-3): 148-152.
15. Jacob FD, Ramaswamy V, Andersen J, Bolduc FV. Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur J Hum Genet 2009: 17 (12): 1577-1581.
16. Brunetti-Pierri N, Paciorkowski AR, Ciccone R et al. Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment. Eur J Hum Genet 2011: 19 (1): 102-107.
17. Yeung A, Bruno D, Scheffer IE et al. 4.45 Mb microduplication in chromosome band 14q12 including FOXG1 in a girl with refractory epilepsy and intellectual impairment. Eur J Med Genet 2009: 52 (6): 440-442.
18. Yao J, Lai E, Stifani S. The winged-helix protein brain factor 1 interacts with groucho and hes proteins to repress transcription. Mol Cell Biol 2001: 21 (6): 1962-1972.
19. Roesch A, Mueller AM, Stempfl T, Moehle C, Landthaler M, Vogt T. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer 2008: 122 (5): 1047-1057.
20. Martynoga B, Morrison H, Price DJ, Mason JO. Foxg1 is required for specification of ventral telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and apoptosis. Dev Biol 2005: 283 (1): 113-127.
21. Marchi M, Guarda A, Bergo A et al. Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells. Epigenetics 2007: 2 (3): 187-197.
22. Kumar A, Kamboj S, Malone BM et al. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci 2008: 121 (Pt 7): 1128-1137.
23. Brancaccio M, Pivetta C, Granzotto M, Filippis C, Mallamaci A. Emx2 and Foxg1 inhibit gliogenesis and promote neuronogenesis. Stem Cells 2010: 28 (7): 1206-1218.
24. Dastidar SG, Landrieu PM, D'mello SR. FoxG1 promotes the survival of postmitotic neurons. J Neurosci 2011: 31 (2): 402-413.
25. Costa M, Marchi M, Cardarelli F et al. Dynamic regulation of ERK2 nuclear translocation and mobility in living cells. J Cell Sci 2006: 119 (Pt 23): 4952-4963.
26. Regad T, Roth M, Bredenkamp N, Illing N, Papalopulu N. The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF. Nat Cell Biol 2007: 9 (5): 531-540.